Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and an MSI status predicting model.
Fu X, Huang J, Zhu J, Fan X, Wang C, Deng W, Tan X, Chen Z, Cai Y, Lin H, Wang G, Zhang N, Zhu Y, Chen J, Zhan H, Huang S, Fang Y, Li Y, Huang Y.
Fu X, et al.
Int J Cancer. 2024 Apr 9. doi: 10.1002/ijc.34946. Online ahead of print.
Int J Cancer. 2024.
PMID: 38594805